1,469 results on '"Borch-Johnsen, K."'
Search Results
52. Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus
53. Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trial
54. Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPAR-γ2) gene in relation to insulin sensitivity among glucose tolerant Caucasians
55. Guía europea de prevención cardiovascular en la práctica clínica. Tercer grupo de trabajo de las sociedades europeas y otras sociedades sobre prevención cardiovascular en la práctica clínica: Constituido por representantes de 8 sociedades y expertos invitados
56. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts
57. Risk scores for predicting type 2 diabetes: using the optimal tool
58. Diabetes in Greenland and its relationship with urbanization
59. The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men
60. The rise and fall of the metabolic syndrome
61. Screening for Type 2 diabetes. Lessons from the ADDITION-Europe study
62. Comparing incident diabetes as defined by fasting plasma glucose or by HbA1c. The AusDiab, Inter99 and DESIR studies
63. O3-3.2 Low vitamin D status and risk of type 2 diabetes: a prospective cohort study
64. THE IMMUNE MARKER SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IS ASSOCIATED WITH NEW-ONSET DIABETES IN NON-SMOKING WOMEN AND MEN
65. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
66. Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1cThe Danish Inter99 study
67. Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland
68. Prospective and retrospective recording of severe hypoglycaemia, and assessment of hypoglycaemia awareness in insulin-treated Type 2 diabetes
69. Socioeconomic factors related to attendance at a Type 2 diabetes screening programme
70. Predictors of future fasting and 2-h post-OGTT plasma glucose levels in middle-aged men and women—the Inter99 study
71. REDUCED GLUCOSE OXIDATION AND ELEVATED FAT OXIDATION PRECEDE THE DEVELOPMENT OF PERIPHERAL INSULIN RESISTANCE IN PRE-DIABETIC INDIVIDUALS WITH IMPAIRED FASTING GLYCAEMIA
72. Functional SOCS1 polymorphisms are associated with variation in obesity in whites
73. Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive individuals
74. Are lifestyle changes achieved after participation in a screening programme for Type 2 diabetes? The ADDITION Study, Denmark
75. A −243A→G polymorphism upstream of the gene encoding GAD65 associates with lower levels of body mass index and glycaemia in a population-based sample of 5857 middle-aged White subjects
76. Studies of associations between the Arg389Gly polymorphism of the β1-adrenergic receptor gene (ADRB1) and hypertension and obesity in 7677 Danish white subjects
77. Severe hypoglycaemia in insulin-treated Type 2 diabetes
78. Genetic analysis of the estrogen-related receptor α and studies of association with obesity and type 2 diabetes
79. Insertion/deletion polymorphism in the angiotensin-l-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy
80. Does screening for diabetes identify a group of patients with high, but potentially modifiable, risk of coronary heart disease?: A1749
81. Type 2 diabetes in Kenya: the role of rural-urban migration: A120
82. Large-scale study of the −232C > G polymorphism of PCK1 in Type 2 diabetes
83. Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey
84. No interactions between polymorphisms in the β3-adrenergic receptor gene and the PPAR-γ gene on the risk of the insulin resistance syndrome in the Danish MONICA cohort
85. Can a screening programme for diabetes be applied to another population?
86. The comparison of venous plasma glucose and whole blood capillary glucose in diagnoses of Type 2 diabetes: a population-based screening study
87. Large-scale studies of the Leu72Met polymorphism of the ghrelin gene in relation to the metabolic syndrome and associated quantitative traits
88. Studies of relationships between the GLUT10 Ala206Thr polymorphism and impaired insulin secretion
89. Session 19 – Clinical male fertility: O-073 Trends in Leydig cell function in Danish men
90. Evidence of an association between genetic variation of the coactivator PGC-1β and obesity
91. Studies of relationships between variation of the human G protein-coupled receptor 40 Gene and Type 2 diabetes and insulin release
92. Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Tercer grupo de trabajo de las sociedades europeas y otras sociedades sobre prevención cardiovascular en la práctica clínica (constituido por representantes de ocho sociedades y expertos invitados)
93. Linking glycemic dysregulation in diabetes to symptoms, comorbidities, and genetics through EHR data mining
94. Studies of the Ala/Val98 polymorphism of the hepatocyte nuclear factor-1α gene and the relationship to β-cell function during an OGTT in glucose-tolerant women with and without previous gestational diabetes mellitus
95. Prevalence of the metabolic syndrome among the Inuit in Greenland. A comparison between two proposed definitions
96. Targeted screening for undiagnosed diabetes reduces the number of diagnostic tests. Inter99(8)
97. Parallel Session 6 – Cardiovascular Diseases I: A randomised non-pharmacological intervention study for prevention of ischaemic heart disease: INTER99
98. Obesity and central fat pattern among Greenland Inuit and a general population of Denmark (Inter99): Relationship to metabolic risk factors
99. Comparability of venous and capillary glucose measurements in blood
100. First referral of diabetic patients to a nephrologist
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.